NewsRx

Search our medical news database

Anesiva, Inc.

Anesiva Raises $45 Million in Common Stock Offering

Published in Medical Verdicts and Law Weekly, December 27th, 2007

Anesiva, Inc. (NASDAQ:ANSV) announced the pricing of a common stock offering of 11,111,111 shares of its common stock at $4.05 per share, which represents no discount to the closing bid price on December 12, 2007, for approximately $45 million in gross proceeds, before deducting underwriting discounts and commissions (approximately $50 million if the underwriters' over-allotment option described below is exercised in full) or approximately $42.9 million after deducting the underwriting discounts and commissions (approximately $47.7 if the underwriters' over-allotment option described below is exercised). All shares of the common stock offered by Anesiva are being sold pursuant to an...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook